文献速递呼吸衰竭与机械通气儿科与产科急症重症综合管理与镇静镇痛

儿童急诊及ICU插管呼吸暂停期间经鼻高流量氧疗对低氧血症及插管成功率的影响:一项随机对照开放标签试验

Effectiveness of nasal high-flow oxygen during apnoea on hypoxaemia and intubation success in paediatric emergency and ICU settings: a randomised, controlled, open-label trial.
PubMed 文献 · Lancet Respir Med · 2025-03-21
一句话结论儿童急诊插管时使用经鼻高流量呼吸暂停氧疗未减少低氧血症事件(12.8% vs 16.2%,aOR 0.74,p=0.15),也未提高首次插管成功率(63.0% vs 59.1%,aOR 1.13,p=0.43)。

该研究为在澳大利亚、新西兰和瑞士10家医院(4个急诊科、10个儿科重症监护病房和1个非产科新生儿重症监护病房)开展的随机、对照、开放标签试验,纳入16岁以下接受紧急气管插管的儿童,1:1随机分配至经鼻高流量呼吸暂停氧疗组或标准治疗组。主要终点为低氧血症事件(SpO2≤90%)和首次尝试插管成功且无血氧饱和度下降。改良意向治疗分析(950次插管)显示,经鼻高流量组低氧血症事件61/476(12.8%)vs 标准治疗组77/474(16.2%),aOR 0.74(97.5%CI 0.46-1.18),p=0.15;首次尝试插管成功300/476(63.0%)vs 280/474(59.1%),aOR 1.13(97.5%CI 0.79-1.62),p=0.43。符合方案分析(905次插管)中,经鼻高流量组低氧血症48/444(10.8%)vs 标准治疗组77/461(16.7%),aOR 0.59(97.5%CI 0.36-0.97),p=0.017;首次尝试插管成功284/444(64.0%)vs 268/461(58.1%),aOR 1.22(97.5%CI 0.87-1.71),p=0.19。作者认为,儿童紧急插管期间使用经鼻高流量未减少低氧血症事件,也未提高首次插管成功率;但符合方案分析中低氧血症事件更少,而首次尝试插管成功且无低氧血症无差异;经鼻高流量在紧急插管中应用的障碍及

要点

  • 改良意向治疗分析中,经鼻高流量组低氧血症事件12.8%(61/476)vs 标准治疗组16.2%(77/474),aOR 0.74(97.5%CI 0.46-1.18),p=0.15,未达统计学显著。
  • 改良意向治疗分析中,首次尝试插管成功经鼻高流量组63.0%(300/476)vs 标准治疗组59.1%(280/474),aOR 1.13(97.5%CI 0.79-1.62),p=0.43,无显著差异。
  • 符合方案分析(905次插管)中,经鼻高流量组低氧血症10.8%(48/444)vs 标准治疗组16.7%(77/461),aOR 0.59(97.5%CI 0.36-0.97),p=0.017。
  • 符合方案分析中,首次尝试插管成功经鼻高流量组64.0%(284/444)vs 标准治疗组58.1%(268/461),aOR 1.22(97.5%CI 0.87-1.71),p=0.19,无显著差异。
  • 作者认为,经鼻高流量在紧急插管中应用的障碍及在生理恶化前放弃插管尝试的原因有待进一步研究,以指导未来研究和插管指南及临床实践建议。

适用人群与场景

  • 纳入标准:在澳大利亚、新西兰和瑞士10家医院(4个急诊科、10个儿科重症监护病房和1个非产科新生儿重症监护病房)接受紧急气管插管的16岁以下儿童。

诊断标准与关键阈值

  • 低氧血症事件定义为血氧饱和度(SpO2)≤90%。

研究设计与关键结果

  • 研究类型:随机、对照、开放标签试验,在澳大利亚、新西兰和瑞士10家医院(4个急诊科、10个儿科重症监护病房和1个非产科新生儿重症监护病房)开展;2017年5月9日至2022年10月22日期间,969名儿童的1069次插管被随机分配至经鼻高流量组(535次插管)或标准治疗组(534次插管)。
  • 主要分析(改良意向治疗)纳入860名儿童的950次插管,经鼻高流量组476次、标准治疗组474次;低氧血症事件经鼻高流量组61/476(12.8%)vs 标准治疗组77/474(16.2%),aOR 0.74(97.5%CI 0.46-1.18),p=0.15;首次尝试插管成功经鼻高流量组300/476(63.0%)vs 标准治疗组280/474(59.1%),aOR 1.13(97.5%CI 0.79-1.62),p=0.43。
  • 符合方案分析纳入905次插管;低氧血症经鼻高流量组48/444(10.8%)vs 标准治疗组77/461(16.7%),aOR 0.59(97.5%CI 0.36-0.97),p=0.017;首次尝试插管成功经鼻高流量组284/444(64.0%)vs 标准治疗组268/461(58.1%),aOR 1.22(97.5%CI 0.87-1.71),p=0.19。

证据类型、等级与局限

  • 证据类型:随机、对照、开放标签试验;试验注册号ACTRN12617000147381,现已完成。
  • 局限:作者指出,经鼻高流量在紧急插管中应用的障碍及在生理恶化前放弃插管尝试的原因有待进一步研究,以指导未来研究和插管指南及临床实践建议。

对床旁实践的改变

  • 作者认为,儿童紧急插管期间使用经鼻高流量未减少低氧血症事件,也未提高首次插管成功率;但符合方案分析中低氧血症事件更少,而首次尝试插管成功且无低氧血症无差异。
  • 作者认为,经鼻高流量在紧急插管中应用的障碍及在生理恶化前放弃插管尝试的原因有待进一步研究,以指导未来研究和插管指南及临床实践建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The use of nasal high-flow (NHF) oxygen for apnoeic oxygenation during emergency paediatric intubation is not universally adopted. Although previous studies suggest potential benefits, it remains unclear whether NHF enhances the likelihood of achieving successful first-attempt intubation without oxygen desaturation in children. We aimed to investigate whether the provision of NHF oxygen during paediatric emergency intubation can improve intubation outcomes.

METHODS: We conducted a randomised, controlled, open-label trial at ten hospitals in Australia, New Zealand, and Switzerland (four emergency departments, ten paediatric intensive care units, and one non-maternity neonatal intensive care unit were included). Children younger than 16 years undergoing emergency endotracheal intubation were eligible for inclusion. Participants were randomly assigned (1:1) to receive either NHF apnoeic oxygenation or standard care during intubation. The primary outcomes were the occurrence of hypoxaemic events (defined as oxygen saturation [SpO2] ≤90%) and successful intubation on the first attempt without desaturation in the modified intention-to-treat population (all intubations in participants for whom prospective or retrospective consent was given and a primary outcome was recorded). This trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12617000147381) and is now completed.

FINDINGS: Between May 9, 2017, and Oct 22, 2022, 1069 intubations in 969 children were randomly assigned to the NHF group (535 intubations) or standard care group (534 intubations). The primary analysis comprised 950 intubations in 860 children, with 476 intubations in the NHF group and 474 in the standard care group. In the NHF group, hypoxaemic events occurred in 61 (12·8%) of 476 intubations, compared with 77 (16·2%) of 474 in the standard care group (adjusted odds ratio [aOR] 0·74; 97·5% CI 0·46-1·18; p=0·15). Successful intubation was achieved at the first attempt in 300 (63·0%) of 476 intubations in the NHF group and 280 (59·1%) of 474 intubations in the standard care group (aOR 1·13; 97·5% CI 0·79-1·62; p=0·43). In the per-protocol analysis of 905 intubations, NHF reduced the rate of hypoxaemia (48 [10·8%] of 444) compared with standard care (77 [16·7%] of 461; aOR 0·59; 97·5% CI 0·36-0·97; p=0·017). In this analysis, first-attempt successful intubation was achieved in 284 (64·0%) of 444 intubations in the NHF group versus 268 (58·1%) of 461 intubations in the standard care group (aOR 1·22; 97·5% CI 0·87-1·71; p=0·19).

INTERPRETATION: The use of NHF during emergency intubation in children did not result in a reduction in hypoxaemic events or an increase in the frequency of successful intubation on the first attempt. However, in the per-protocol analysis, there were fewer hypoxaemic events but no difference in successful intubation without hypoxaemia on first attempt. Barriers to the application of NHF during emergency intubation and the reasons for abandoning intubation attempts before physiological compromise should be further investigated to inform future research and recommendations for intubation guidelines and clinical practice.

FUNDING: Thrasher Research Fund (USA), National Health and Medical Research Council (Australia), and the Emergency Medicine Foundation (Australia).

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. George S, Williams T, Humphreys S, et al. Effectiveness of nasal high-flow oxygen during apnoea on hypoxaemia and intubation success in paediatric emergency and ICU settings: a randomised, controlled, open-label trial. Lancet Respir Med. 2025. PMID: 40127666. doi:10.1016/S2213-2600(25)00074-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。